Michele Colucci, Esq.

Michele Colucci, Esq. is a seasoned professional with extensive experience in the intersection of healthcare and technology. As the Managing Partner and CEO of DigitalDx Ventures since October 2018, Michele focuses on investing in innovative companies utilizing artificial intelligence and big data in diagnostics and digital therapeutics. Michele holds board member positions at Optina Diagnostics, Biotia, GLX ANALYTIX, and Delphi Diagnostics Inc., and serves as Board Chair at Prime Genomics. Additionally, Michele acts as West Coast Ambassador to the Nobel Laureate Foundation, engaging with Nobel Laureates and young scientists to inspire innovative solutions to global challenges. With an academic background that includes a JD from Georgetown University Law Center, an MFA from The American Film Institute, and a BA in English and Philosophy from Georgetown University, Michele leverages a diverse skill set to advise companies like eHealthAnalytics and Quantellia LLC on improving healthcare predictions and decision-making through data and artificial intelligence.